The information on this website is not intended for diagnosis or treatment. Please consult your physician for health concerns.

+90 850 321 50 00

Large-Vessel Vasculitis PET-CT Monitoring

Use of 18F-FDG PET-CT for diagnosis, activity assessment and treatment response monitoring in giant cell arteritis and Takayasu arteritis.

Written by: Saygı Hospital Health Guide Editorial Board
Last updated:

This content has been compiled by the Saygı Hospital Health Guide Editorial Board and is periodically reviewed by a specialist physician.

References (5)

This content is for informational purposes only and does not constitute medical advice. You can book an appointment at our Dahiliye (İç Hastalıkları) department. Book Appointment →

What is Large-Vessel Vasculitis PET-CT Monitoring?

Large-vessel vasculitides include giant cell arteritis (GCA) and Takayasu arteritis (TAK), both of which involve granulomatous inflammation of the aorta and its main branches. 18F-FDG positron emission tomography integrated with computed tomography (PET-CT) is increasingly used to demonstrate vascular wall hypermetabolism reflective of active inflammation.

PET-CT plays a role in early diagnosis, especially in patients with non-classical or extracranial GCA presentations and atypical Takayasu involvement. Combined with CT angiography, it can simultaneously assess inflammation and structural vascular damage including stenoses and aneurysms.

In treatment monitoring, serial PET-CT examinations help quantify residual inflammation, guide tapering of glucocorticoids and identify subclinical relapse. Standardized scoring systems and reduction of imaging-induced radiation are areas of ongoing research.

Symptoms

Headache and scalp tenderness
Jaw claudication
Visual disturbances
Limb claudication
Carotidynia
Fever of unknown origin
Weight loss and fatigue

Risk Factors

Age >50 (GCA)
Asian or Hispanic ancestry (TAK)
Female sex
Polymyalgia rheumatica overlap
Genetic HLA susceptibility
Recent infection trigger
Atypical large-vessel involvement

When to See a Doctor?

If you experience any of the following symptoms, seek medical attention promptly:

  • Diagnostic uncertainty in suspected GCA or TAK
  • Persistent inflammation despite therapy
  • Concern for relapse during steroid taper
  • Aneurysmal complications under follow-up
  • Pre-biologic baseline assessment
  • Treatment response evaluation

Treatment Methods

01
Glucocorticoid induction therapy
02
Steroid-sparing agents (methotrexate, azathioprine)
03
Tocilizumab in GCA
04
Vascular intervention for critical stenoses
05
Aspirin in select patients
06
Serial PET-CT and MRA monitoring
07
Multidisciplinary rheumatology and vascular care

Which Department to Visit?

You can visit our Dahiliye (İç Hastalıkları) department for these complaints. Our specialist physicians will create the most suitable treatment plan for you.

Learn About Dahiliye (İç Hastalıkları) Department

Let us help you

You can make an appointment with our specialists or contact us for your concerns.

Book AppointmentContact Us

Related Health Topics

Other articles from the same department you may want to explore.

Anaemia

Dahiliye (İç Hastalıkları)

Anaemia is a low haemoglobin level that reduces oxygen delivery, causing fatigue, pallor, and shortness of breath. It is not a disease itself but a sign of many underlying conditions. Most cases are correctable with appropriate diagnosis and treatment.

Iron Deficiency Anaemia

Dahiliye (İç Hastalıkları)

Iron deficiency anaemia develops when dietary intake, absorption, or losses create an iron shortfall, most often affecting women and children. Identifying the underlying cause is the core of management, alongside iron replacement.

Vitamin B12 Deficiency

Dahiliye (İç Hastalıkları)

Vitamin B12 deficiency can cause megaloblastic anaemia, neurological symptoms, and cognitive impairment. Early treatment with intramuscular or oral B12 largely prevents irreversible complications.

Hypertension (High Blood Pressure) Management

Dahiliye (İç Hastalıkları)

Hypertension is often called the silent killer because it progresses symptom-free for years and can damage the heart, brain, kidneys, and eyes. Regular monitoring, lifestyle change, and evidence-based drug therapy dramatically reduce cardiovascular risk.

Chronic Kidney Disease

Dahiliye (İç Hastalıkları)

Chronic kidney disease is one of the most common complications of chronic conditions such as diabetes and hypertension, and can be silent in its early stages.

Hepatitis B (HBV)

Dahiliye (İç Hastalıkları)

Hepatitis B is a DNA virus infection causing acute and chronic hepatitis with risk of cirrhosis and hepatocellular carcinoma; diagnosis integrates HBsAg, HBeAg, anti-HBc, and HBV DNA with management based on disease phase using nucleos(t)ide analogues (entecavir, tenofovir) and universal infant vaccination.

Hepatitis C (HCV)

Dahiliye (İç Hastalıkları)

Hepatitis C is an RNA virus causing chronic hepatitis that may progress to cirrhosis and hepatocellular carcinoma; modern direct-acting antiviral (DAA) pangenotypic regimens (sofosbuvir/velpatasvir, glecaprevir/pibrentasvir) achieve sustained virologic response over 95% in 8–12 weeks with universal adult screening and cure for nearly all patients.

Fatty Liver Disease

Dahiliye (İç Hastalıkları)

Non-alcoholic fatty liver disease (NAFLD) is closely related to obesity and metabolic syndrome and is largely reversible with early treatment.

Health Disclaimer: The information on this page is prepared for general informational purposes only. It does not replace medical diagnosis and treatment. Please consult your physician for your complaints. Saygı Hospital does not accept responsibility for actions taken based on the information on this page.